Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance nifedipine and progesterone for threatened preterm labor
2012-002547-15Phase 3Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone and nifedipine in Preterm labor (PTL), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Preterm delivery before 37 weeks of gestation. Started Sep 2012; status: terminated.
02
Drugs
progesteronenifedipine
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2012-002547-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002547-15.